We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
iShares Europe ETF
IEV
$1.6B
| $1.23M | 0.02% |
27,695
+1,300
| +5% | +$56.8K |
2014 Q1
4 quarters
|
|
252
DELISTED
Hologic
HOLX
| $1.22M | 0.02% |
36,858
-2,955
| -7% | -$90.7K |
2014 Q1
4 quarters
|
|
|
FULLL
253
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
| $1.22M | 0.02% |
47,800
+7,600
| +19% | +$196K |
2013 Q2
7 quarters
|
|
|
254
Tesla
TSLA
$1.41T
| $1.17M | 0.02% |
92,970
-2,642,805
| -97% | -$35.7M |
2013 Q2
7 quarters
|
|
255
Invesco Water Resources ETF
PHO
$1.95B
| $1.17M | 0.02% |
46,850
+1,815
| +4% | +$45.3K |
2013 Q2
7 quarters
|
|
|
WFM
256
DELISTED
Whole Foods Market Inc
WFM
| $1.16M | 0.02% |
22,282
-11,032
| -33% | -$591K |
2013 Q2
7 quarters
|
|
|
SBY
257
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $1.16M | 0.02% |
71,616
| – | – |
2013 Q2
7 quarters
|
|
258
Medtronic
MDT
$121B
| $1.15M | 0.02% |
14,791
+2,198
| +17% | +$167K |
2013 Q2
7 quarters
|
|
259
Xencor
XNCR
$1.74B
| $1.15M | 0.02% |
75,210
+29,469
| +64% | +$465K |
2014 Q3
2 quarters
|
|
|
MHNB.CL
260
DELISTED
Maiden Holdings North America
MHNB.CL
| $1.14M | 0.02% |
42,600
+1,800
| +4% | +$47.9K |
2013 Q2
7 quarters
|
|
261
Nike
NKE
$55.6B
| $1.11M | 0.02% |
22,100
+880
| +4% | +$42.1K |
2013 Q2
7 quarters
|
|
262
Automatic Data Processing
ADP
$114B
| $1.11M | 0.02% |
12,928
| – | – |
2013 Q2
7 quarters
|
|
263
DELISTED
Leggett & Platt
LEG
| $1.1M | 0.02% |
23,881
-623
| -3% | -$27.8K |
2014 Q2
3 quarters
|
|
264
Under Armour
UAA
$2.1B
| $1.09M | 0.02% |
26,968
+19,420
| +257% | +$714K |
2014 Q1
4 quarters
|
|
265
UnitedHealth
UNH
$360B
| $1.08M | 0.02% |
9,146
+482
| +6% | +$53.5K |
2013 Q2
7 quarters
|
|
266
State Street Financial Select Sector SPDR ETF
XLF
$51.7B
| $1.08M | 0.02% |
51,143
+90
| +0.2% | +$1.9K |
2013 Q4
5 quarters
|
|
267
Emerson Electric
EMR
$90B
| $1.08M | 0.02% |
19,014
-1,126
| -6% | -$65.4K |
2013 Q2
7 quarters
|
|
|
CEO
268
DELISTED
CNOOC Limited
CEO
| $1.06M | 0.02% |
7,509
+1,245
| +20% | +$172K |
2014 Q2
3 quarters
|
|
269
Weyerhaeuser
WY
$14.2B
| $1.06M | 0.02% |
31,977
+1,861
| +6% | +$65.2K |
2014 Q1
4 quarters
|
|
|
ARUN
270
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $1.05M | 0.02% |
42,845
-3,106
| -7% | -$62.5K |
2014 Q3
2 quarters
|
|
271
LyondellBasell Industries
LYB
$20.5B
| $1.05M | 0.02% |
11,910
+3,453
| +41% | +$290K |
2013 Q2
7 quarters
|
|
272
Franklin Electric
FELE
$4.44B
| $1.04M | 0.02% |
27,313
+2,495
| +10% | +$89.4K |
2013 Q2
7 quarters
|
|
|
KMPA
273
DELISTED
Kemper Corporation
KMPA
| $1.03M | 0.02% |
39,200
+1,700
| +5% | +$44.7K |
2014 Q1
4 quarters
|
|
|
DTV
274
DELISTED
DIRECTV COM STK (DE)
DTV
| $1.02M | 0.02% |
12,028
-100
| -0.8% | -$8.64K |
2013 Q2
7 quarters
|
|
275
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $1.02M | 0.02% |
27,918
+7,932
| +40% | +$288K |
2014 Q3
2 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.